Sanjeev Handa (S Handa)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Venues

Clinical and experimental dermatology

Vascular health and risk management

Mycoses

Dermatologic therapy

Post Graduate Institute of Medical Education and Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Post Graduate Institute of Medical Education and Research Oct 01 2013

India

Professor and Head :: Dermatology, Venereology & Leprology

Publications

Hitaishi Mehta, Tarun Narang, Sunil Dogra, Sanjeev Handa, Juniali Hatwal, Akash Batta
Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review. Vascular health and risk management 20 (2024)
Hitaishi Mehta, Tarun Narang, Sunil Dogra, Sanjeev Handa, Juniali Hatwal, Akash Batta
Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review. Vascular health and risk management 20 (2024)
Dipika Shaw, Sunil Dogra, Shreya Singh, Shikha R Shah, Tarun Narang, Harsimran Kaur, Kamini Walia, Anup K Ghosh, Sanjeev Handa, Arunoloke Chakrabarti, Shivaprakash Mandya Rudramurthy
Prolonged treatment of dermatophytosis caused by Trichophyton indotinea with terbinafine or itraconazole impacts better outcomes irrespective of mutation in the squalene epoxidase gene. Mycoses 67 (8) (2024)
Hitaishi Mehta, Tarun Narang, Sunil Dogra, Sanjeev Handa, Juniali Hatwal, Akash Batta
Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review. Vascular health and risk management 20 (2024)
Dipika Shaw, Sunil Dogra, Shreya Singh, Shikha R Shah, Tarun Narang, Harsimran Kaur, Kamini Walia, Anup K Ghosh, Sanjeev Handa, Arunoloke Chakrabarti, Shivaprakash Mandya Rudramurthy
Prolonged treatment of dermatophytosis caused by Trichophyton indotinea with terbinafine or itraconazole impacts better outcomes irrespective of mutation in the squalene epoxidase gene. Mycoses 67 (8) (2024)
Namrata Singh, Sanjeev Handa, Rahul Mahajan, Naresh Sachdeva, Dipankar De
Comparison of the efficacy and cost-effectiveness of an immunologically targeted low-dose rituximab protocol with the conventional rheumatoid arthritis protocol in severe pemphigus. Clinical and experimental dermatology 47 (8) (2022)
Rahul Mahajan, Anuradha Bishnoi, S Manjunath, P Vignesh, D Suri, M Gopal, D Chatterjee, M Jamwal, Dipankar De, R Das, Sanjeev Handa, A Kubba, M Batrani, B D Radotra
Severe epidermolysis bullosa/Kindler syndrome-like phenotype of an autoinflammatory syndrome in a child. Clinical and experimental dermatology 46 (4) (2021)
Sanjeev Handa, Hitaishi Mehta, Anuradha Bishnoi, Keshavamurthy Vinay, Rahul Mahajan, Tarun Narang, Muthu Sendhil Kumaran, Dipankar De, Sunil Dogra, Davinder Parsad
Teledermatology during the COVID-19 pandemic: Experience at a tertiary care centre in North India. Dermatologic therapy 34 (4) (2021)
Akanksha Kaushik, Rahul Mahajan, Dipankar De, Sanjeev Handa
Paediatric morphoea: a holistic review. Part 1: epidemiology, aetiopathogenesis and clinical classification. Clinical and experimental dermatology 45 (6) (2020)
Akanksha Kaushik, Rahul Mahajan, Dipankar De, Sanjeev Handa
Paediatric morphoea: a holistic review. Part 2: diagnosis, measures of disease activity, management and natural history. Clinical and experimental dermatology 45 (6) (2020)

Sanjeev Handa.css-eqlu8i{font-size:small;padding-left:4px;} (S Handa)

Publication Activity (10 Years)

Top Topics

Top Venues

Sanjeev Handa (S Handa)